Name | Number of supported studies | Average coverage | |
---|---|---|---|
non-classical monocyte | 4 studies | 25% ± 9% |
Insufficient scRNA-seq data for expression of TNFRSF8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 432.08 | 455 / 459 | 47% | 1.11 | 526 / 1118 |
lung | 80% | 114.26 | 460 / 578 | 59% | 1.70 | 685 / 1155 |
stomach | 80% | 107.72 | 288 / 359 | 45% | 1.02 | 130 / 286 |
uterus | 74% | 105.82 | 125 / 170 | 44% | 1.25 | 201 / 459 |
skin | 57% | 69.99 | 1035 / 1809 | 50% | 2.07 | 234 / 472 |
bladder | 67% | 57.52 | 14 / 21 | 35% | 0.95 | 176 / 504 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.77 | 29 / 29 |
adipose | 100% | 639.81 | 1203 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2409.17 | 917 / 929 | 0% | 0 | 0 / 0 |
spleen | 98% | 209.43 | 236 / 241 | 0% | 0 | 0 / 0 |
esophagus | 60% | 69.77 | 860 / 1445 | 36% | 1.18 | 65 / 183 |
intestine | 54% | 61.34 | 522 / 966 | 34% | 0.85 | 180 / 527 |
ovary | 26% | 27.77 | 46 / 180 | 56% | 2.15 | 242 / 430 |
heart | 76% | 132.67 | 658 / 861 | 0% | 0 | 0 / 0 |
kidney | 43% | 44.02 | 38 / 89 | 26% | 0.45 | 238 / 901 |
tonsil | 0% | 0 | 0 / 0 | 69% | 2.64 | 31 / 45 |
thymus | 16% | 15.39 | 104 / 653 | 50% | 1.10 | 301 / 605 |
muscle | 63% | 65.19 | 508 / 803 | 0% | 0 | 0 / 0 |
brain | 24% | 97.22 | 633 / 2642 | 28% | 1.14 | 195 / 705 |
pancreas | 1% | 1.25 | 4 / 328 | 49% | 1.17 | 88 / 178 |
blood vessel | 50% | 68.64 | 670 / 1335 | 0% | 0 | 0 / 0 |
prostate | 20% | 19.36 | 49 / 245 | 5% | 0.09 | 23 / 502 |
eye | 0% | 0 | 0 / 0 | 11% | 0.32 | 9 / 80 |
liver | 2% | 1.20 | 4 / 226 | 7% | 0.18 | 30 / 406 |
adrenal gland | 3% | 2.41 | 9 / 258 | 5% | 0.27 | 12 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0032759 | Biological process | positive regulation of TRAIL production |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0002020 | Molecular function | protease binding |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
Gene name | TNFRSF8 |
Protein name | TNFRSF8 protein Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30) TNF receptor superfamily member 8 |
Synonyms | D1S166E CD30 |
Description | FUNCTION: Receptor for TNFSF8/CD30L . May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B . . |
Accessions | ENST00000413146.6 [P28908-2] D6RAG8 P28908 ENST00000514649.5 A5D8T4 Q6GMU3 ENST00000263932.7 [P28908-1] ENST00000417814.3 [P28908-3] |